Article
CENPF Knockdown Inhibits Adriamycin Chemoresistance In Triple Negative Breast Cancer Mediated By Rb-E2F1 Axis
2022-11-07
Abstract excerpt
<title>Abstract</title> <p>Background: Frequent developed resistance leads to early relapse and short survival in Triple-negative breast cancer (TNBC). Targeting DNA damage response (DDR) has become an effective strategy for overcoming TNBC chemoresistance. CENPF (centromere protein) is a key regulator of cell cycle progression, but its role in TNBC chemotherapy resistance remains unclear. <h4>Methods:</h4> We U...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 59ef2b41-91ce-53dc-ab4e-29e7652825e7
- DOI
- 10.21203/rs.3.rs-1853542/v2
